Short-term efficacy of microwave ablation in the treatment of liver cancer and its effect on immune function

Table 1 Comparison of general information, n (%)/mean ± SD

General information	Liver cancer resection group (n = 35)	Liver cancer ablation group (n = 35)	t/χ2	P value
Age (yr)	56.59 ± 5.83	56.74 ± 6.02	0.106	0.916
Gender			0.072	0.788
Male	26 (74.29)	25 (71.43)
Female	9 (25.71)	10 (28.57)
Tumor number			1.942	0.163
Single	29 (82.86)	24 (68.57)
Multiple	6 (17.14)	11 (31.43)
Maximum diameter of tumor (cm)	2.85 ± 0.74	2.91 ± 0.79	0.328	0.744
Child–Pugh classification			0.254	0.615
A-level	24 (68.57)	22 (62.86)
B-level	11 (31.43)	13 (37.14)
Adjacent site of tumor			0.516	0.915
Paracholecystic	11 (31.43)	13 (37.15)
Diaphragm	5 (14.29)	6 (17.14)
Inferior margin of the liver	12 (34.28)	10 (28.57)
Beside the hepatic vein	7 (20.00)	6 (17.14)